VANCOUVER, British Columbia, April 30, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Allscripts (NASDAQ:MDRX), Chesapeake Energy (NYSE:CHK), Expedia (NASDAQ:EXPE), Western Digital (NYSE:WDC), Arena Pharmaceuticals (NASDAQ:ARNA), and Warner Chilcott (NASDAQ:WCRX).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX): Abnormal trading volume of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) was found on April 27, reaching 86.93 million shares, 25 times heavier than usual day trading. Allscripts tumbled US$5.72 per share (equivalent to 35.71%), where stock prices fell to US$10.30. In the past 52 weeks, Allscripts share prices have been bracketed by a low of US$8.99 and a high of US$21.92, and are now at US$10.30, 15% above that low price. Are insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?
Read Full Report: http://www.insiderslab.com/PR3/043012A/MDRX/Allscripts.pdf
Chesapeake Energy Corporation (NYSE:CHK): According to the recent report of Chesapeake Energy Corporation (NYSE:CHK), its Board of Directors has determined to negotiate the early termination of the company's Founder Well Participation Program (FWPP) with its Chief Executive Officer, Aubrey K. McClendon. The FWPP was approved by shareholders for a 10-year term (2005 through 2015). In the last trading session, Chesapeake Energy advanced 0.91% to US$17.72. Share prices of Chesapeake Energy have traded as high as US$35.75 per share and as low as US$16.78 in the past 52 weeks. The stock was traded above average volume with 50.14 million shares traded, 29.5 million shares more than its daily average. Investors may want to find out how company insiders like Executive Officers and Directors are thinking about the future business prospects of the company. Check this insider trade report for CHK here.
Read Full Report: http://www.insiderslab.com/PR3/043012A/CHK/ChesapeakeEnergy.pdf
Expedia Inc. (NASDAQ:EXPE): Expedia Inc. (NASDAQ:EXPE) and Amadeus have recently achieved a multi-year content and technology agreement for North America. By market close, Expedia Inc. soared 23.54% higher, moving up US$7.68 to US$40.31 per share. There were 24.63 million stock shares traded, which was 7 times more than average volume. The stock has been moving within a range of US$27.28 - US$65.78 over the past 52-week. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in EXPE are starting to buy more company shares. See insider trade report for EXPE here.
Read Full Report: http://www.insiderslab.com/PR3/043012A/EXPE/Expedia.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Western Digital Corp. (NYSE:WDC):
Read Full Report: http://www.insiderslab.com/PR3/043012A/WDC/WesternDigital.pdf
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA):
Read Full Report: http://www.insiderslab.com/PR3/043012A/ARNA/ArenaPharmaceuticals.pdf
Warner Chilcott Plc (NASDAQ:WCRX):
Read Full Report: http://www.insiderslab.com/PR3/043012A/WCRX/WarnerChilcott.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.